Is Citius Oncology, Inc. overvalued?

Citius Oncology, Inc. (CTOR) — key valuation metrics and fundamentals.

No verdict

Price

$0.91

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$84.6M

Dividend yield

0.0%

Return on equity

-99.5%

Sector

Healthcare

Fair value compares CTOR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks